This panel took place at LSI USA '25 Emerging Medtech Summit in Dana Point, CA.
Industry experts Hanson Gifford and Andrew Cleeland join moderator Chris Cleary to discuss navigating medtech build-to-buy deals, exploring critical factors that determine successful partnerships and deal consummation.
This panel featured:
Chris Cleary — Biomergence Capital LLC
Andrew Cleeland — Fogartyinnovation
Hanson Gifford — The Foundry & Lightstone Ventures
Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits
Follow us on social!
LinkedIn: https://www.linkedin.com/company/life-science-intelligence/
Twitter: https://twitter.com/lsintelligence
Instagram: https://www.instagram.com/lifescienceintelligence/
Facebook: https://www.facebook.com/LifeScienceIntelligence/
Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw